263 related articles for article (PubMed ID: 27332719)
1. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
Shin JK; Kim JY
J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
[TBL] [Abstract][Full Text] [Related]
4. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
[TBL] [Abstract][Full Text] [Related]
5. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
[TBL] [Abstract][Full Text] [Related]
6. Characterization of tumor and adjacent peritumoral stroma in patients with breast cancer using high-resolution diffusion-weighted imaging: Correlation with pathologic biomarkers.
Shin HJ; Park JY; Shin KC; Kim HH; Cha JH; Chae EY; Choi WJ
Eur J Radiol; 2016 May; 85(5):1004-11. PubMed ID: 27130063
[TBL] [Abstract][Full Text] [Related]
7. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
8. Prediction of low-risk breast cancer using perfusion parameters and apparent diffusion coefficient.
Shin HJ; Kim HH; Shin KC; Sung YS; Cha JH; Lee JW; Son BH; Ahn SH
Magn Reson Imaging; 2016 Feb; 34(2):67-74. PubMed ID: 26523654
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
[TBL] [Abstract][Full Text] [Related]
10. Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio.
Ko ES; Han BK; Kim RB; Cho EY; Ahn S; Nam SJ; Ko EY; Shin JH; Hahn SY
Radiology; 2014 Apr; 271(1):30-7. PubMed ID: 24475830
[TBL] [Abstract][Full Text] [Related]
11. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
Karan B; Pourbagher A; Torun N
J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
[TBL] [Abstract][Full Text] [Related]
13. ADC at 3.0 T as a noninvasive biomarker for preoperative prediction of Ki67 expression in invasive ductal carcinoma of breast.
Shen L; Zhou G; Tong T; Tang F; Lin Y; Zhou J; Wang Y; Zong G; Zhang L
Clin Imaging; 2018; 52():16-22. PubMed ID: 29501957
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
Liu C; Liang C; Liu Z; Zhang S; Huang B
Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging of mucinous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings.
Woodhams R; Kakita S; Hata H; Iwabuchi K; Umeoka S; Mountford CE; Hatabu H
AJR Am J Roentgenol; 2009 Jul; 193(1):260-6. PubMed ID: 19542422
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI of breast lesions: a prospective clinical investigation of the quantitative imaging biomarker characteristics of reproducibility, repeatability, and diagnostic accuracy.
Spick C; Bickel H; Pinker K; Bernathova M; Kapetas P; Woitek R; Clauser P; Polanec SH; Rudas M; Bartsch R; Helbich TH; Baltzer PA
NMR Biomed; 2016 Oct; 29(10):1445-53. PubMed ID: 27553252
[TBL] [Abstract][Full Text] [Related]
17. Histogram analysis of apparent diffusion coefficient map of diffusion-weighted MRI in endometrial cancer: a preliminary correlation study with histological grade.
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Dec; 55(10):1270-7. PubMed ID: 24316663
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
[TBL] [Abstract][Full Text] [Related]
19. Whole Volume Apparent Diffusion Coefficient (ADC) Histogram as a Quantitative Imaging Biomarker to Differentiate Breast Lesions: Correlation with the Ki-67 Proliferation Index.
Guo Y; Kong QC; Li LQ; Tang WJ; Zhang WL; Ning GY; Xue J; Zhou QW; Liang YY; Wu M; Jiang XQ
Biomed Res Int; 2021; 2021():4970265. PubMed ID: 34258262
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.
Kim JY; Kim JJ; Hwangbo L; Lee JW; Lee NK; Nam KJ; Choo KS; Kang T; Park H; Son Y; Grimm R
Eur Radiol; 2020 Jan; 30(1):66-76. PubMed ID: 31385051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
